Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.


Officer Retirement

On August 2, 2021, Brian G. Drazba, the Chief Financial Officer and Secretary of MEI Pharma, Inc. (the "Company"), and the Company entered into a Transition and Retirement Agreement with the Company (the "Retirement Agreement"). On December 21, 2021, Mr. Drazba and the Company mutually agreed to extend the term of Mr. Drazba's employment to June 30, 2022 (or an earlier date determined by either party), pursuant to a letter agreement dated December 21, 2021 (the "Letter Agreement"). Mr. Drazba will be eligible to receive the separation benefits under the Retirement Agreement if his employment terminates for any reason other than for cause on or prior to June 30, 2022. Additionally, consistent with the extension of employment, if Mr. Drazba's employment terminates without cause on or prior to June 30, 2022 (i) Mr. Drazba will vest in the same number of options as of his retirement date as he would have had he continued employment through the first anniversary of the retirement date, and (ii) he will be able to exercise his vested stock options through the first anniversary of his retirement date, or until the expiration of the option term, if earlier, subject to the terms of the applicable option agreements. The foregoing benefits are subject to Mr. Drazba signing and not revoking a release of claims and complying with applicable restrictive covenants. The parties may mutually agree to extend the term of the Retirement Agreement.

The foregoing descriptions of the Retirement Agreement and the Letter Agreement are qualified in their entirety by reference to the full text of the Transition and Retirement Agreement, which was filed as Exhibit 10.1 to the Company's Current Report on Form 8-K on August 5, 2021, and the Letter Agreement, which is filed herewith as Exhibit 10.1 and incorporated by reference.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



Exhibit
  No.       Description

10.1          Letter Agreement between Brian G. Drazba and MEI Pharma, Inc. dated
            as of December 21, 2021

104         Cover Page Interactive Data File (the cover page XBRL tags are
            embedded within the inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses